Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Applied Microbiology and Biotechnology|January 10, 2002
An improved procedure for production of human epidermal growth factor from recombinant E. coliW Y Tong, S J Yao, Z Q Zhu, et al.Prikladnaia Biokhimiia I Mikrobiologiia|August 2, 2008
Expression and purification of soluble B lymphocyte stimulator from recombinant Escherichia coliQ R Guo, W Y Tong, D Z Wei, et al.Journal of Chemotherapy (Florence, Italy)|March 5, 2004
Inhibition of liver cancer cell proliferation and migration by a combination of (-)-epigallocatechin-3-gallate and ascorbic acidD Z Wei, J Y Yang, J W Liu, et al.HIV Medicine|September 7, 2013
Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherenceJ McAllister, P Read, A McNulty, et al.European Review for Medical and Pharmacological Sciences|February 4, 2014
Antimicrobial effects of Caulerpa sertularioides extract on foodborne diarrhea-caused bacteriaI Darah, W Y Tong, S Nor-Afifah, et al.Internal Medicine Journal|September 24, 2010
Transmission of triple-class, drug-resistant HIV-1 in AustraliaW W Y Tong, J McAllister, P A White, et al.Microbiology and Immunology|April 3, 1998
Follow-up study of hypervariable region sequences of the hepatitis C virus (HCV) genome in an infant with delayed anti-HCV antibody responsesY Katayama, H Tajiri, K Tada, et al.HIV Medicine|September 7, 2013
Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adultsW W Y Tong, R J Hillman, A D Kelleher, et al.HIV Medicine|January 28, 2014
Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeksM Bloch, W W Y Tong, J Hoy, et al.Biochemical and Biophysical Research Communications|January 13, 1997
Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virusS Ishido, S Muramatsu, T Fujita, et al.Pageof 2